Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota

About this trial

Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neural stimulators (INSs) have many parameters that may be adjusted, and could be tuned to achieve very patient specific therapies. This study will develop a platform for stimulation setting optimization based on power spectral density (PSD) measures.

Eligibility criteria

Qualifiers

medically refractory epilepsy

already have a deep brain stimulator in place

Disqualifiers

severe dementia at investigator discretion

Trial design

Treatments tested in this trial

  • PS and OS stimulation order 1
  • PS and OS stimulation order 2
  • PS and OS stimulation order 3

Treatment groups

20 Participants
are divided into 3 treatment groups

Sponsors and collaborators